Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of biologics in chronic rhinosinusitis: a systematic review
Isma Z. Iqbal, Stephen Shih‐Teng Kao, Eng H. Ooi
International Forum of Allergy & Rhinology (2019) Vol. 10, Iss. 2, pp. 165-174
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

International consensus statement on allergy and rhinology: rhinosinusitis 2021
Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, et al.
International Forum of Allergy & Rhinology (2020) Vol. 11, Iss. 3, pp. 213-739
Open Access | Times Cited: 621
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
Paul Oykhman, Fernando Aleman Paramo, Jean Bousquet, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1286-1295
Open Access | Times Cited: 160
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Ioana Agache, Yang Song, Pablo Alonso‐Coello, et al.
Allergy (2021) Vol. 76, Iss. 8, pp. 2337-2353
Open Access | Times Cited: 107
Biologics for chronic rhinosinusitis
Lee‐Yee Chong, Patorn Piromchai, Steve Sharp, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 66
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma
Nicola Lombardo, Corrado Pelaia, Marco Ciriolo, et al.
International Journal of Immunopathology and Pharmacology (2020) Vol. 34
Open Access | Times Cited: 60
Biologics for chronic rhinosinusitis
Lee‐Yee Chong, Patorn Piromchai, Steve Sharp, et al.
Cochrane library (2020)
Open Access | Times Cited: 59
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Gayatri Patel, Anju T. Peters
Ear Nose & Throat Journal (2020) Vol. 100, Iss. 1, pp. 44-47
Open Access | Times Cited: 45
Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis
Andrew Thamboo, Shaun Kilty, Ian Witterick, et al.
Journal of Otolaryngology - Head and Neck Surgery (2021) Vol. 50, Iss. 1
Open Access | Times Cited: 38
Dupilumab: An emerging therapy in allergic fungal rhinosinusitis
Adeeb A. Bulkhi, Ahmad A. Mirza, Abdullah J. Aburiziza, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 3, pp. 100638-100638
Open Access | Times Cited: 23
Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases
Katarzyna Antosz, Joanna Batko, Marta Błażejewska, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1531-1531
Open Access | Times Cited: 4
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Public Knowledge and Factors Associated With Familiarity of Treatments for Rhinosinusitis
Tyler J. Gallagher, Rishabh Shah, Michelle Koh, et al.
OTO Open (2025) Vol. 9, Iss. 1
Open Access
Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review
Christine Kim, Joseph K. Han, Tara J. Wu, et al.
Otolaryngology (2020) Vol. 164, Iss. 1, pp. 57-66
Closed Access | Times Cited: 30
A real-world assessment of asthma with chronic rhinosinusitis
Fabio Luigi Massimo Ricciardolo, Stefano Levra, Andrea Elio Sprio, et al.
Annals of Allergy Asthma & Immunology (2020) Vol. 125, Iss. 1, pp. 65-71
Closed Access | Times Cited: 21
Canadian multidisciplinary expert consensus on the use of biologics in upper airways: A Delphi study
Andrew Thamboo, Melissa Lee, Mohit Bhutani, et al.
Journal of Otolaryngology - Head and Neck Surgery (2023) Vol. 52, Iss. 1
Open Access | Times Cited: 7
Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps
Christopher M. Low, Allan Wang, Michael Yong, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 7, pp. 1249-1252
Closed Access | Times Cited: 2
Advances in co-pathogenesis of the united airway diseases
Xinjun Xu, Jiali Yin, Yujuan Yang, et al.
Respiratory Medicine (2024) Vol. 225, pp. 107580-107580
Closed Access | Times Cited: 2
Predictors of persistent disease in biologic treated type 2 diffuse/eosinophilic chronic rhinosinusitis undergoing surgery
Lu Hui Png, Larry Kalish, Raewyn G. Campbell, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 5, pp. 909-918
Open Access | Times Cited: 6
Monoclonal Antibodies and Airway Diseases
Annina Lyly, Anu Laulajainen‐Hongisto, Philippe Gevaert, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9477-9477
Open Access | Times Cited: 15
A Decade of Pathogenesis Advances in Non-Type 2 Inflammatory Endotypes in Chronic Rhinosinusitis: 2012–2022
Na Cui, Xuewei Zhu, Chen Zhao, et al.
International Archives of Allergy and Immunology (2023) Vol. 184, Iss. 12, pp. 1237-1253
Open Access | Times Cited: 5
Elevated Serum Leptin Levels in Patients With Eosinophilic Chronic Rhinosinusitis
Yoshimasa Imoto, Shigeharu Ueki, Yukinori Kato, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 8
A Practical Clinical Protocol for Monitoring Patients with Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyposis Treated with Biologics
Stefano Millarelli, Antonella Loperfido, Fulvio Mammarella, et al.
Allergy & Rhinology (2022) Vol. 13
Open Access | Times Cited: 8
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations
Amarbir S. Gill, Jeremiah A. Alt, Kara Y. Detwiller, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 9, pp. 1758-1782
Closed Access | Times Cited: 8
Cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis from 2004 to 2023
Guan‐Jiang Huang, Zhi‐Jun Fan, Biao-Qing Lu
Frontiers in Big Data (2024) Vol. 7
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top